Medtronic’s GI revenue reached $671 million, while renal care solutions revenue decreased low-double digits, according to the report.
Medtronic’s organic GI revenue also decreased by 11 percent. Medtronic’s overall revenue decreased 3 percent to $7.6 billion worldwide.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.